Profile data is unavailable for this security.
About the company
Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
- Revenue in AUD (TTM)674.03m
- Net income in AUD15.43m
- Incorporated2020
- Employees5.12k
- LocationAustralian Clinical Labs Ltd1868-1892 Dandenong Road, ClaytonMELBOURNE 2000AustraliaAUS
- Phone+61 30045-3688
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eureka Group Holdings Ltd | 39.24m | 17.71m | 161.44m | 42.00 | 9.12 | 1.09 | 8.71 | 4.11 | 0.0587 | 0.0587 | 0.13 | 0.4907 | 0.1626 | -- | 64.27 | -- | 7.34 | 6.02 | 7.54 | 6.21 | 53.43 | 50.40 | 45.13 | 33.60 | -- | -- | 0.3849 | 24.62 | 22.42 | 10.04 | 134.41 | -- | 91.86 | -- |
| Capitol Health Ltd | 229.29m | 6.14m | 239.86m | -- | 39.20 | 1.79 | 7.28 | 1.05 | 0.0057 | 0.0057 | 0.214 | 0.1256 | 0.7237 | -- | 47.34 | -- | 1.97 | 3.05 | 2.27 | 3.55 | 92.94 | 92.41 | 2.73 | 4.24 | -- | -- | 0.5219 | 130.91 | 13.81 | 11.90 | -203.87 | -- | 19.92 | 4.56 |
| Pacific Smiles Group Ltd | 173.72m | 6.61m | 264.11m | 800.00 | 37.79 | 4.39 | 7.01 | 1.52 | 0.0438 | 0.0438 | 1.09 | 0.3774 | 0.9257 | 3.88 | 57.63 | -- | 3.52 | 3.61 | 4.44 | 4.55 | 86.25 | 85.00 | 3.80 | 3.68 | 0.5689 | 2.95 | 0.5862 | 78.81 | 18.54 | 9.60 | 153.43 | -18.18 | -4.27 | -15.55 |
| Australian Unity Ltd | 2.00bn | 43.47m | 282.93m | 7.70k | -- | -- | 2.91 | 0.1416 | -- | -- | -- | -- | 0.2346 | -- | -- | 259,666.80 | 0.5105 | 0.5917 | -- | -- | -- | -- | 2.18 | 2.65 | -- | 2.25 | 0.6373 | -- | 36.50 | 12.70 | 24.19 | -- | -5.72 | -- |
| Australian Clinical Labs Ltd | 674.03m | 15.43m | 484.40m | 5.12k | 31.30 | 2.92 | 3.43 | 0.7187 | 0.0767 | 0.0767 | 3.35 | 0.8221 | 1.14 | 6.77 | 9.12 | 131,774.80 | 2.65 | 15.43 | 3.92 | 24.15 | 82.75 | 81.10 | 2.32 | 9.32 | 0.5735 | 2.89 | 0.6646 | 44.29 | -29.99 | 12.95 | -79.86 | -- | -4.29 | -- |
| Monash IVF Group Ltd | 235.97m | 23.97m | 564.97m | 867.00 | 23.74 | 2.04 | 13.75 | 2.39 | 0.0611 | 0.0611 | 0.6014 | 0.7095 | 0.5572 | 3.88 | 13.19 | 272,169.60 | 5.67 | 5.66 | 6.74 | 6.33 | 89.52 | 89.40 | 10.17 | 11.02 | 0.2846 | 9.63 | 0.3024 | 68.46 | 11.07 | 7.23 | 18.65 | 0.4511 | 33.48 | -4.72 |
| Integral Diagnostics Ltd | 456.31m | -57.85m | 580.23m | 2.00k | -- | 1.93 | -- | 1.27 | -0.2485 | -0.2485 | 1.94 | 1.29 | 0.5758 | 13.71 | 21.44 | 228,157.00 | -7.30 | 4.02 | -8.19 | 4.55 | 95.23 | 95.17 | -12.68 | 6.92 | 0.7415 | 2.04 | 0.5462 | 70.64 | 22.13 | 18.36 | 71.47 | 10.68 | 30.60 | -5.01 |
| Healius Ltd | 1.69bn | -984.10m | 878.58m | 10.50k | -- | 0.8365 | -- | 0.5193 | -1.45 | -1.43 | 2.53 | 1.45 | 0.4782 | 6.27 | 9.78 | 161,123.80 | -27.81 | 0.6198 | -33.52 | 0.7441 | 87.07 | 86.75 | -58.17 | 1.32 | 0.4713 | 1.07 | 0.606 | 195.89 | -25.43 | 0.027 | -229.96 | -- | -5.86 | -- |
| Regis Healthcare Ltd | 950.89m | -14.68m | 1.16bn | 9.00k | -- | 253.43 | 10.42 | 1.22 | -0.0488 | -0.0488 | 3.16 | 0.0152 | 0.5274 | -- | 45.73 | 105,654.40 | -0.8145 | 0.0329 | -10.71 | 0.149 | -- | -- | -1.54 | 0.0763 | 0.0716 | -- | 0.9412 | 3,882.96 | 7.16 | 7.27 | 26.67 | -- | -25.03 | -11.97 |
| Holder | Shares | % Held |
|---|---|---|
| Ethical Partners Funds Management Pty Ltd.as of 06 Feb 2024 | 19.62m | 9.72% |
| Superannuation Funds Management Corp. of South Australiaas of 01 Mar 2024 | 14.31m | 7.09% |
| Australian Ethical Investments Ltd. (Investment Management)as of 05 Feb 2024 | 12.29m | 6.09% |
| Yarra Funds Management Ltd.as of 21 Aug 2023 | 10.69m | 5.30% |
| Regal Funds Management Pty Ltd.as of 18 Nov 2022 | 10.07m | 4.99% |
| River Capital Pty Ltd.as of 14 Sep 2022 | 7.70m | 3.82% |
| Investors Mutual Ltd.as of 31 Mar 2024 | 5.04m | 2.50% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 4.34m | 2.15% |
| First Sentier Investors (Australia) IM Ltd.as of 09 Apr 2024 | 3.71m | 1.84% |
| Vanguard Investments Australia Ltd.as of 29 Feb 2024 | 2.33m | 1.15% |
